Actavis reviews strategic options in Europe

25 July 2013 - Deborah Wilkes

Archived

Generics firm Actavis is considering a range of strategic alternatives, including divestment, for its operations in a number of countries in Western Europe.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: